| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 5.90e-06 | 2 | 49 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 5.90e-06 | 2 | 49 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 1.77e-05 | 3 | 49 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 1.14e-04 | 102 | 49 | 4 | GO:0005249 | |
| GeneOntologyMolecularFunction | potassium channel activity | 2.73e-04 | 128 | 49 | 4 | GO:0005267 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 3.15e-04 | 54 | 49 | 3 | GO:0001223 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NRG1 FLYWCH1 DTX1 IQCB1 GNB4 WWTR1 MSL1 CREBBP EP300 MAPK8IP3 | 4.34e-04 | 1160 | 49 | 10 | GO:0030674 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 5.24e-04 | 152 | 49 | 4 | GO:0022843 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 6.07e-04 | 15 | 49 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 7.46e-04 | 167 | 49 | 4 | GO:0015079 | |
| GeneOntologyMolecularFunction | JUN kinase binding | 7.84e-04 | 17 | 49 | 2 | GO:0008432 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 7.84e-04 | 17 | 49 | 2 | GO:0099508 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.03e-03 | 182 | 49 | 4 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.07e-03 | 184 | 49 | 4 | GO:0022832 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 1.20e-03 | 21 | 49 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.33e-03 | 334 | 49 | 5 | GO:0022836 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | NRG1 FLYWCH1 DTX1 IQCB1 GNB4 WWTR1 MSL1 CREBBP EP300 MAPK8IP3 | 1.45e-03 | 1356 | 49 | 10 | GO:0060090 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.49e-03 | 343 | 49 | 5 | GO:0005261 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 2.42e-03 | 562 | 49 | 6 | GO:0003712 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 3.72e-03 | 37 | 49 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 4.91e-03 | 140 | 49 | 3 | GO:0001221 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 5.00e-03 | 43 | 49 | 2 | GO:0043548 | |
| GeneOntologyMolecularFunction | protein kinase binding | 5.16e-03 | 873 | 49 | 7 | GO:0019901 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 5.21e-03 | 459 | 49 | 5 | GO:0005216 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 5.22e-03 | 875 | 49 | 7 | GO:0019904 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 5.50e-03 | 465 | 49 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 6.44e-03 | 303 | 49 | 4 | GO:0003713 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 6.97e-03 | 51 | 49 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | signaling receptor complex adaptor activity | 7.78e-03 | 54 | 49 | 2 | GO:0030159 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 7.99e-03 | 167 | 49 | 3 | GO:0031490 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 8.06e-03 | 55 | 49 | 2 | GO:0061733 | |
| GeneOntologyBiologicalProcess | head development | ATRN NRG1 PALS1 ROGDI IER3IP1 ASPM KCNQ2 AFDN GNB4 CREBBP EP300 MAPK8IP3 | 5.46e-07 | 919 | 46 | 12 | GO:0060322 |
| GeneOntologyBiologicalProcess | neuron development | TANC2 NRG1 PALS1 KANK1 KIDINS220 HECW2 IQSEC1 KCNQ2 AFDN CREBBP EP300 PTK2 MAPK8IP3 | 1.21e-05 | 1463 | 46 | 13 | GO:0048666 |
| GeneOntologyBiologicalProcess | brain development | 1.55e-05 | 859 | 46 | 10 | GO:0007420 | |
| GeneOntologyBiologicalProcess | developmental growth | 2.57e-05 | 911 | 46 | 10 | GO:0048589 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 2.91e-05 | 4 | 46 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | central nervous system development | ATRN NRG1 PALS1 ROGDI IER3IP1 ASPM KCNQ2 AFDN GNB4 PTK2 MAPK8IP3 | 4.88e-05 | 1197 | 46 | 11 | GO:0007417 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 5.53e-05 | 612 | 46 | 8 | GO:0010975 | |
| GeneOntologyBiologicalProcess | synapse assembly | 5.98e-05 | 308 | 46 | 6 | GO:0007416 | |
| GeneOntologyBiologicalProcess | growth | ATRN NRG1 IER3IP1 KCNJ8 APBA1 ASPM AFDN WWTR1 EXOSC2 EP300 PTK2 | 6.49e-05 | 1235 | 46 | 11 | GO:0040007 |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 8.48e-05 | 202 | 46 | 5 | GO:0051963 | |
| GeneOntologyBiologicalProcess | neuron projection development | TANC2 NRG1 KANK1 KIDINS220 HECW2 IQSEC1 AFDN CREBBP EP300 PTK2 MAPK8IP3 | 9.27e-05 | 1285 | 46 | 11 | GO:0031175 |
| GeneOntologyBiologicalProcess | dendrite development | 9.51e-05 | 335 | 46 | 6 | GO:0016358 | |
| GeneOntologyBiologicalProcess | response to temperature stimulus | 9.73e-05 | 208 | 46 | 5 | GO:0009266 | |
| GeneOntologyBiologicalProcess | positive regulation of cell growth | 1.09e-04 | 213 | 46 | 5 | GO:0030307 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 2.09e-04 | 387 | 46 | 6 | GO:0050807 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 2.33e-04 | 395 | 46 | 6 | GO:0050803 | |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 2.51e-04 | 55 | 46 | 3 | GO:0043330 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | 2.61e-04 | 257 | 46 | 5 | GO:0007163 | |
| GeneOntologyBiologicalProcess | dendritic spine development | 2.73e-04 | 141 | 46 | 4 | GO:0060996 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 3.15e-04 | 418 | 46 | 6 | GO:0051962 | |
| GeneOntologyBiologicalProcess | response to dsRNA | 3.75e-04 | 63 | 46 | 3 | GO:0043331 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 4.08e-04 | 819 | 46 | 8 | GO:0120039 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 4.32e-04 | 826 | 46 | 8 | GO:0048858 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 4.35e-04 | 625 | 46 | 7 | GO:0051960 | |
| GeneOntologyBiologicalProcess | negative regulation of synapse assembly | 5.02e-04 | 15 | 46 | 2 | GO:0051964 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | 5.06e-04 | 846 | 46 | 8 | GO:0120035 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid acetylation | 5.72e-04 | 16 | 46 | 2 | GO:0006474 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to heat | 5.72e-04 | 16 | 46 | 2 | GO:1900034 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | 5.77e-04 | 863 | 46 | 8 | GO:0031344 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 6.05e-04 | 309 | 46 | 5 | GO:1901888 | |
| GeneOntologyBiologicalProcess | establishment of cell polarity | 6.46e-04 | 177 | 46 | 4 | GO:0030010 | |
| GeneOntologyBiologicalProcess | forebrain development | 7.22e-04 | 489 | 46 | 6 | GO:0030900 | |
| GeneOntologyBiologicalProcess | memory | 7.31e-04 | 183 | 46 | 4 | GO:0007613 | |
| GeneOntologyBiologicalProcess | synapse organization | 7.49e-04 | 685 | 46 | 7 | GO:0050808 | |
| GeneOntologyBiologicalProcess | telencephalon development | 8.37e-04 | 332 | 46 | 5 | GO:0021537 | |
| GeneOntologyBiologicalProcess | positive regulation of growth | 9.18e-04 | 339 | 46 | 5 | GO:0045927 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 9.81e-04 | 198 | 46 | 4 | GO:0048813 | |
| GeneOntologyBiologicalProcess | negative regulation of synapse organization | 9.95e-04 | 21 | 46 | 2 | GO:1905809 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine autophosphorylation | 1.09e-03 | 22 | 46 | 2 | GO:0038083 | |
| GeneOntologyBiologicalProcess | regulation of dendritic spine development | 1.10e-03 | 91 | 46 | 3 | GO:0060998 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 1.11e-03 | 354 | 46 | 5 | GO:0050769 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 1.12e-03 | 1194 | 46 | 9 | GO:0000902 | |
| GeneOntologyBiologicalProcess | positive regulation of response to wounding | 1.17e-03 | 93 | 46 | 3 | GO:1903036 | |
| GeneOntologyBiologicalProcess | stimulatory C-type lectin receptor signaling pathway | 1.19e-03 | 23 | 46 | 2 | GO:0002223 | |
| GeneOntologyBiologicalProcess | cellular response to lectin | 1.19e-03 | 23 | 46 | 2 | GO:1990858 | |
| GeneOntologyBiologicalProcess | response to lectin | 1.19e-03 | 23 | 46 | 2 | GO:1990840 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 1.25e-03 | 748 | 46 | 7 | GO:0048667 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 3.63e-05 | 78 | 50 | 4 | GO:0048787 | |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 6.64e-05 | 91 | 50 | 4 | GO:0008076 | |
| GeneOntologyCellularComponent | potassium channel complex | 1.12e-04 | 104 | 50 | 4 | GO:0034705 | |
| GeneOntologyCellularComponent | presynaptic active zone | 3.59e-04 | 141 | 50 | 4 | GO:0048786 | |
| GeneOntologyCellularComponent | presynaptic membrane | 5.13e-04 | 277 | 50 | 5 | GO:0042734 | |
| GeneOntologyCellularComponent | axon | 1.16e-03 | 891 | 50 | 8 | GO:0030424 | |
| GeneOntologyCellularComponent | nuclear body | 1.26e-03 | 903 | 50 | 8 | GO:0016604 | |
| GeneOntologyCellularComponent | mitotic spindle | 1.35e-03 | 201 | 50 | 4 | GO:0072686 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.48e-03 | 94 | 50 | 3 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 1.98e-03 | 104 | 50 | 3 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 2.26e-03 | 109 | 50 | 3 | GO:1902493 | |
| GeneOntologyCellularComponent | cation channel complex | 2.39e-03 | 235 | 50 | 4 | GO:0034703 | |
| HumanPheno | Aortic isthmus hypoplasia | 1.46e-05 | 2 | 20 | 2 | HP:0034227 | |
| HumanPheno | Plantar crease between first and second toes | 1.46e-05 | 2 | 20 | 2 | HP:0008107 | |
| HumanPheno | High axial triradius | 1.46e-05 | 2 | 20 | 2 | HP:0001042 | |
| HumanPheno | Humoral immunodeficiency | 4.38e-05 | 3 | 20 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 4.38e-05 | 3 | 20 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 4.38e-05 | 3 | 20 | 2 | HP:0005895 | |
| HumanPheno | Laryngeal cartilage malformation | 4.38e-05 | 3 | 20 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 4.38e-05 | 3 | 20 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 4.38e-05 | 3 | 20 | 2 | HP:0000756 | |
| HumanPheno | Delayed myelination | 5.87e-05 | 280 | 20 | 7 | HP:0012448 | |
| HumanPheno | Deep plantar creases | 6.58e-05 | 21 | 20 | 3 | HP:0001869 | |
| HumanPheno | Trichiasis | 8.75e-05 | 4 | 20 | 2 | HP:0001128 | |
| HumanPheno | Widened distal phalanges | 8.75e-05 | 4 | 20 | 2 | HP:0006200 | |
| HumanPheno | Visceral hemangioma | 8.75e-05 | 4 | 20 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 8.75e-05 | 4 | 20 | 2 | HP:0011087 | |
| HumanPheno | Vascular ring | 8.75e-05 | 4 | 20 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 8.75e-05 | 4 | 20 | 2 | HP:0031207 | |
| HumanPheno | Broad hallux phalanx | 9.94e-05 | 24 | 20 | 3 | HP:0010059 | |
| HumanPheno | Minor feet anomalies | 1.27e-04 | 26 | 20 | 3 | HP:0010613 | |
| HumanPheno | Abnormal feet morphology | 1.27e-04 | 26 | 20 | 3 | HP:0010611 | |
| HumanPheno | Broad distal phalanx of finger | 1.43e-04 | 27 | 20 | 3 | HP:0009836 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 1.45e-04 | 5 | 20 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 1.45e-04 | 5 | 20 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 1.45e-04 | 5 | 20 | 2 | HP:0030421 | |
| HumanPheno | Large foramen magnum | 2.18e-04 | 6 | 20 | 2 | HP:0002700 | |
| HumanPheno | Full cheeks | 2.32e-04 | 151 | 20 | 5 | HP:0000293 | |
| HumanPheno | Thick eyebrow | 2.54e-04 | 154 | 20 | 5 | HP:0000574 | |
| HumanPheno | Deviated nasal septum | 3.04e-04 | 7 | 20 | 2 | HP:0004411 | |
| HumanPheno | Disturbance of facial expression | 3.40e-04 | 36 | 20 | 3 | HP:0005324 | |
| HumanPheno | Deeply set eye | 3.99e-04 | 266 | 20 | 6 | HP:0000490 | |
| HumanPheno | Pilomatrixoma | 5.19e-04 | 9 | 20 | 2 | HP:0030434 | |
| HumanPheno | Cervical cord compression | 5.19e-04 | 9 | 20 | 2 | HP:0002341 | |
| HumanPheno | Motor delay | TANC2 ROGDI KIDINS220 HECW2 ASPM IQSEC1 KCNQ2 CREBBP EXOSC2 EP300 MAPK8IP3 | 5.44e-04 | 1018 | 20 | 11 | HP:0001270 |
| HumanPheno | Frontal hirsutism | 6.47e-04 | 10 | 20 | 2 | HP:0011335 | |
| HumanPheno | Abnormal hallux phalanx morphology | 7.06e-04 | 46 | 20 | 3 | HP:0010057 | |
| HumanPheno | Broad phalanx of the toes | 7.52e-04 | 47 | 20 | 3 | HP:0010174 | |
| HumanPheno | Abnormal subclavian artery morphology | 7.89e-04 | 11 | 20 | 2 | HP:0031251 | |
| HumanPheno | Delayed ability to walk | 8.16e-04 | 304 | 20 | 6 | HP:0031936 | |
| HumanPheno | Facial grimacing | 1.11e-03 | 13 | 20 | 2 | HP:0000273 | |
| HumanPheno | Keloids | 1.11e-03 | 13 | 20 | 2 | HP:0010562 | |
| HumanPheno | Parietal foramina | 1.30e-03 | 14 | 20 | 2 | HP:0002697 | |
| HumanPheno | Duplication of phalanx of hallux | 1.30e-03 | 14 | 20 | 2 | HP:0010066 | |
| HumanPheno | Hypoplastic aortic arch | 1.30e-03 | 14 | 20 | 2 | HP:0012304 | |
| HumanPheno | Abnormal lateral ventricle morphology | 1.39e-03 | 129 | 20 | 4 | HP:0030047 | |
| HumanPheno | Social and occupational deterioration | 1.49e-03 | 15 | 20 | 2 | HP:0007086 | |
| HumanPheno | Duplication of phalanx of toe | 1.49e-03 | 15 | 20 | 2 | HP:0010181 | |
| HumanPheno | Abnormal myelination | 1.55e-03 | 622 | 20 | 8 | HP:0012447 | |
| HumanPheno | Delayed gross motor development | 1.67e-03 | 481 | 20 | 7 | HP:0002194 | |
| HumanPheno | Square face | 1.70e-03 | 16 | 20 | 2 | HP:0000321 | |
| HumanPheno | Premature thelarche | 1.92e-03 | 17 | 20 | 2 | HP:0010314 | |
| MousePheno | abnormal synaptic transmission | TANC2 COLEC12 NRG1 KANK1 KIDINS220 DTX1 KCNJ8 APBA1 IQSEC1 KCNQ2 AFDN CREBBP MAPK8IP3 | 1.20e-05 | 1070 | 43 | 13 | MP:0003635 |
| MousePheno | abnormal synaptic physiology | TANC2 COLEC12 NRG1 KANK1 KIDINS220 DTX1 KCNJ8 APBA1 IQSEC1 KCNQ2 AFDN CREBBP MAPK8IP3 | 1.28e-05 | 1076 | 43 | 13 | MP:0021009 |
| MousePheno | abnormal CNS synaptic transmission | TANC2 COLEC12 NRG1 KANK1 KIDINS220 DTX1 APBA1 IQSEC1 KCNQ2 AFDN CREBBP MAPK8IP3 | 2.78e-05 | 985 | 43 | 12 | MP:0002206 |
| Domain | Nuc_rcpt_coact_CREBbp | 6.74e-06 | 2 | 49 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 6.74e-06 | 2 | 49 | 2 | PF08214 | |
| Domain | KIX | 6.74e-06 | 2 | 49 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 6.74e-06 | 2 | 49 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 6.74e-06 | 2 | 49 | 2 | IPR031162 | |
| Domain | DUF902 | 6.74e-06 | 2 | 49 | 2 | PF06001 | |
| Domain | K_chnl_volt-dep_KCNQ2 | 6.74e-06 | 2 | 49 | 2 | IPR003947 | |
| Domain | - | 6.74e-06 | 2 | 49 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 6.74e-06 | 2 | 49 | 2 | IPR010303 | |
| Domain | - | 6.74e-06 | 2 | 49 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 6.74e-06 | 2 | 49 | 2 | PF09030 | |
| Domain | - | 6.74e-06 | 2 | 49 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 6.74e-06 | 2 | 49 | 2 | PF02135 | |
| Domain | ZF_TAZ | 6.74e-06 | 2 | 49 | 2 | PS50134 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 6.74e-06 | 2 | 49 | 2 | IPR013178 | |
| Domain | KAT11 | 6.74e-06 | 2 | 49 | 2 | SM01250 | |
| Domain | Znf_TAZ | 6.74e-06 | 2 | 49 | 2 | IPR000197 | |
| Domain | KIX_dom | 6.74e-06 | 2 | 49 | 2 | IPR003101 | |
| Domain | KIX | 6.74e-06 | 2 | 49 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 6.74e-06 | 2 | 49 | 2 | PS51727 | |
| Domain | PDZ | 3.33e-05 | 141 | 49 | 5 | PF00595 | |
| Domain | PDZ | 4.20e-05 | 148 | 49 | 5 | SM00228 | |
| Domain | - | 4.48e-05 | 150 | 49 | 5 | 2.30.42.10 | |
| Domain | PDZ | 4.63e-05 | 151 | 49 | 5 | PS50106 | |
| Domain | PDZ | 4.78e-05 | 152 | 49 | 5 | IPR001478 | |
| Domain | K_chnl_volt-dep_KCNQ | 6.71e-05 | 5 | 49 | 2 | IPR003937 | |
| Domain | K_chnl_volt-dep_KCNQ_C | 6.71e-05 | 5 | 49 | 2 | IPR013821 | |
| Domain | KCNQ_channel | 6.71e-05 | 5 | 49 | 2 | PF03520 | |
| Domain | VG_K_chnl | 8.76e-05 | 33 | 49 | 3 | IPR028325 | |
| Domain | Nuc_rcpt_coact | 1.00e-04 | 6 | 49 | 2 | IPR009110 | |
| Domain | Ion_trans_dom | 2.26e-04 | 114 | 49 | 4 | IPR005821 | |
| Domain | Ion_trans | 2.26e-04 | 114 | 49 | 4 | PF00520 | |
| Domain | WW | 2.54e-04 | 47 | 49 | 3 | PF00397 | |
| Domain | WW | 2.70e-04 | 48 | 49 | 3 | SM00456 | |
| Domain | WW_DOMAIN_2 | 3.23e-04 | 51 | 49 | 3 | PS50020 | |
| Domain | WW_DOMAIN_1 | 3.23e-04 | 51 | 49 | 3 | PS01159 | |
| Domain | WW_dom | 3.43e-04 | 52 | 49 | 3 | IPR001202 | |
| Domain | IQ | 8.56e-04 | 71 | 49 | 3 | PF00612 | |
| Domain | ZZ | 1.00e-03 | 18 | 49 | 2 | PF00569 | |
| Domain | ZF_ZZ_2 | 1.00e-03 | 18 | 49 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 1.00e-03 | 18 | 49 | 2 | PS01357 | |
| Domain | Znf_ZZ | 1.12e-03 | 19 | 49 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 1.12e-03 | 19 | 49 | 2 | SM00291 | |
| Domain | IQ_motif_EF-hand-BS | 1.70e-03 | 90 | 49 | 3 | IPR000048 | |
| Domain | IQ | 1.87e-03 | 93 | 49 | 3 | PS50096 | |
| Domain | Bromodomain_CS | 2.11e-03 | 26 | 49 | 2 | IPR018359 | |
| Domain | BROMODOMAIN_1 | 4.24e-03 | 37 | 49 | 2 | PS00633 | |
| Domain | Bromodomain | 4.46e-03 | 38 | 49 | 2 | PF00439 | |
| Domain | PH_dom-like | 5.04e-03 | 426 | 49 | 5 | IPR011993 | |
| Domain | BROMODOMAIN_2 | 5.18e-03 | 41 | 49 | 2 | PS50014 | |
| Pathway | REACTOME_POTASSIUM_CHANNELS | 5.15e-06 | 103 | 35 | 5 | M1073 | |
| Pathway | WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1 | 1.12e-05 | 18 | 35 | 3 | M48069 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 5.44e-05 | 30 | 35 | 3 | M936 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 5.64e-05 | 411 | 35 | 7 | M735 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 5.96e-05 | 5 | 35 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 5.96e-05 | 5 | 35 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 5.96e-05 | 5 | 35 | 2 | M48023 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 5.96e-05 | 5 | 35 | 2 | M27228 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 8.69e-05 | 35 | 35 | 3 | M48246 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 8.93e-05 | 6 | 35 | 2 | M22062 | |
| Pathway | REACTOME_POTASSIUM_CHANNELS | 9.75e-05 | 98 | 35 | 4 | MM14545 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 1.25e-04 | 7 | 35 | 2 | MM1573 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 1.62e-04 | 43 | 35 | 3 | M1056 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 1.66e-04 | 8 | 35 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 1.66e-04 | 8 | 35 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 1.66e-04 | 8 | 35 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 1.66e-04 | 8 | 35 | 2 | M46443 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 1.96e-04 | 220 | 35 | 5 | M27794 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 2.11e-04 | 47 | 35 | 3 | M7946 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 2.13e-04 | 9 | 35 | 2 | M47451 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 2.66e-04 | 10 | 35 | 2 | M27945 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 3.25e-04 | 11 | 35 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 3.25e-04 | 11 | 35 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 3.25e-04 | 11 | 35 | 2 | M26924 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 3.89e-04 | 12 | 35 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 3.89e-04 | 12 | 35 | 2 | M27765 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 5.35e-04 | 14 | 35 | 2 | M27808 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 6.16e-04 | 15 | 35 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 6.16e-04 | 15 | 35 | 2 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 6.16e-04 | 15 | 35 | 2 | MM1439 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 6.16e-04 | 15 | 35 | 2 | M953 | |
| Pathway | BIOCARTA_RACC_PATHWAY | 6.16e-04 | 15 | 35 | 2 | M22002 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 7.03e-04 | 16 | 35 | 2 | M27121 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 7.03e-04 | 16 | 35 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 7.03e-04 | 16 | 35 | 2 | MM1420 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 7.03e-04 | 16 | 35 | 2 | M8516 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 7.03e-04 | 16 | 35 | 2 | M27940 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 7.64e-04 | 296 | 35 | 5 | M27869 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 7.74e-04 | 73 | 35 | 3 | M638 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 7.96e-04 | 17 | 35 | 2 | MM1509 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 7.96e-04 | 17 | 35 | 2 | M48025 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 8.05e-04 | 74 | 35 | 3 | M616 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 8.94e-04 | 18 | 35 | 2 | M26942 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 8.94e-04 | 18 | 35 | 2 | MM14775 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 9.97e-04 | 19 | 35 | 2 | M18933 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 9.97e-04 | 19 | 35 | 2 | M46442 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 1.09e-03 | 82 | 35 | 3 | M1002 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.11e-03 | 20 | 35 | 2 | M27881 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 1.22e-03 | 21 | 35 | 2 | M39593 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 1.22e-03 | 21 | 35 | 2 | M27485 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 1.33e-03 | 335 | 35 | 5 | MM14503 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.34e-03 | 22 | 35 | 2 | MM1370 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 1.34e-03 | 22 | 35 | 2 | MM1443 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 1.47e-03 | 23 | 35 | 2 | M2821 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 1.47e-03 | 91 | 35 | 3 | M39700 | |
| Pathway | WP_ANGIOGENESIS | 1.60e-03 | 24 | 35 | 2 | M39556 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.60e-03 | 24 | 35 | 2 | M13404 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 1.71e-03 | 96 | 35 | 3 | M27784 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.73e-03 | 25 | 35 | 2 | M27880 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 1.81e-03 | 98 | 35 | 3 | M48247 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 1.87e-03 | 26 | 35 | 2 | M2499 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 1.87e-03 | 26 | 35 | 2 | M32 | |
| Pathway | WP_IL6_SIGNALING_PATHWAY | 1.92e-03 | 100 | 35 | 3 | MM15826 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 2.17e-03 | 28 | 35 | 2 | M27254 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 2.49e-03 | 30 | 35 | 2 | M207 | |
| Pathway | PID_NECTIN_PATHWAY | 2.49e-03 | 30 | 35 | 2 | M72 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY | 2.66e-03 | 31 | 35 | 2 | M47554 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 2.83e-03 | 32 | 35 | 2 | M39521 | |
| Pathway | WP_PRION_DISEASE_PATHWAY | 2.83e-03 | 32 | 35 | 2 | M39636 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 3.20e-03 | 34 | 35 | 2 | M39771 | |
| Pathway | PID_HIF2PATHWAY | 3.20e-03 | 34 | 35 | 2 | M44 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 3.23e-03 | 120 | 35 | 3 | M48233 | |
| Pathway | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | 3.38e-03 | 35 | 35 | 2 | M1075 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 3.58e-03 | 36 | 35 | 2 | M633 | |
| Pathway | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | 3.58e-03 | 36 | 35 | 2 | MM14544 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 3.98e-03 | 38 | 35 | 2 | M27757 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 3.98e-03 | 38 | 35 | 2 | M27255 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 4.19e-03 | 39 | 35 | 2 | MM14604 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 4.31e-03 | 133 | 35 | 3 | MM15529 | |
| Pathway | PID_FOXM1_PATHWAY | 4.40e-03 | 40 | 35 | 2 | M176 | |
| Pathway | PID_IFNG_PATHWAY | 4.40e-03 | 40 | 35 | 2 | M161 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 4.62e-03 | 41 | 35 | 2 | MM14546 | |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 4.84e-03 | 42 | 35 | 2 | M41828 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 4.84e-03 | 42 | 35 | 2 | M17541 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 5.07e-03 | 43 | 35 | 2 | M41827 | |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 5.07e-03 | 43 | 35 | 2 | MM15679 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 5.17e-03 | 142 | 35 | 3 | M27233 | |
| Pathway | PID_HNF3A_PATHWAY | 5.31e-03 | 44 | 35 | 2 | M285 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 5.31e-03 | 44 | 35 | 2 | MM15678 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 5.31e-03 | 44 | 35 | 2 | M27295 | |
| Pubmed | 1.04e-07 | 7 | 51 | 3 | 16332960 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 2.11e-06 | 2 | 51 | 2 | 34845315 | |
| Pubmed | The role of PTPN13 in invasion and metastasis of lung squamous cell carcinoma. | 2.11e-06 | 2 | 51 | 2 | 23906871 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 19729597 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 15860545 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 29460469 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 2.11e-06 | 2 | 51 | 2 | 24551300 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 33911074 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 9018065 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 24648406 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 30135524 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 39287984 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 2.11e-06 | 2 | 51 | 2 | 16596650 | |
| Pubmed | KCNQ2 and KCNQ5 form heteromeric channels independent of KCNQ3. | 2.11e-06 | 2 | 51 | 2 | 35320039 | |
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 2.11e-06 | 2 | 51 | 2 | 29217654 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 20717166 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 10049825 | ||
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 2.11e-06 | 2 | 51 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 2.11e-06 | 2 | 51 | 2 | 29170789 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 25893291 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 11559821 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 21555743 | ||
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 2.11e-06 | 2 | 51 | 2 | 12646247 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 32576962 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 19822209 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 24522976 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 11867645 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 2.11e-06 | 2 | 51 | 2 | 21847097 | |
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 2.11e-06 | 2 | 51 | 2 | 11963968 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 2.11e-06 | 2 | 51 | 2 | 34813504 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 9528808 | ||
| Pubmed | Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines. | 2.11e-06 | 2 | 51 | 2 | 12696060 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 20301699 | ||
| Pubmed | CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain. | 2.11e-06 | 2 | 51 | 2 | 36109165 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 24639469 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 37816914 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 12242694 | ||
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 2.11e-06 | 2 | 51 | 2 | 11438528 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 10918613 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 31182547 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 35502657 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 30635043 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 31898871 | ||
| Pubmed | Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. | 2.11e-06 | 2 | 51 | 2 | 27648933 | |
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 2.11e-06 | 2 | 51 | 2 | 30888860 | |
| Pubmed | Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. | 2.11e-06 | 2 | 51 | 2 | 27881443 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 19272189 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 10610021 | ||
| Pubmed | Emerging roles of p300/CBP in autophagy and autophagy-related human disorders. | 2.11e-06 | 2 | 51 | 2 | 37314181 | |
| Pubmed | Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. | 2.11e-06 | 2 | 51 | 2 | 12397173 | |
| Pubmed | CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding. | 2.11e-06 | 2 | 51 | 2 | 15641773 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 21263457 | ||
| Pubmed | Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. | 2.11e-06 | 2 | 51 | 2 | 32690000 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 9733868 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 30953353 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 21803292 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 9811832 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 24089570 | ||
| Pubmed | Rubinstein-Taybi syndrome in Chinese population with four novel mutations. | 2.11e-06 | 2 | 51 | 2 | 33063428 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 34506759 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 22177454 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 15706485 | ||
| Pubmed | AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer. | 2.11e-06 | 2 | 51 | 2 | 39266679 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 22303793 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 38969045 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 34732714 | ||
| Pubmed | Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition. | 2.11e-06 | 2 | 51 | 2 | 34019788 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 20819935 | ||
| Pubmed | Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. | 6.32e-06 | 3 | 51 | 2 | 14716005 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 18070920 | ||
| Pubmed | The acetylation of transcription factor HBP1 by p300/CBP enhances p16INK4A expression. | 6.32e-06 | 3 | 51 | 2 | 21967847 | |
| Pubmed | CBP and p300 are essential for renin cell identity and morphological integrity of the kidney. | 6.32e-06 | 3 | 51 | 2 | 19252086 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 27903646 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 12748286 | ||
| Pubmed | MRTF/SRF dependent transcriptional regulation of TAZ in breast cancer cells. | 6.32e-06 | 3 | 51 | 2 | 26885614 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 10075656 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 24340053 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 19273602 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 15649887 | ||
| Pubmed | Expression patterns of histone acetyltransferases p300 and CBP during murine tooth development. | 6.32e-06 | 3 | 51 | 2 | 22179676 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 17410209 | ||
| Pubmed | DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes. | 6.32e-06 | 3 | 51 | 2 | 26951377 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 12226752 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 12890507 | ||
| Pubmed | CBP/p300 and SIRT1 are involved in transcriptional regulation of S-phase specific histone genes. | 6.32e-06 | 3 | 51 | 2 | 21789216 | |
| Pubmed | Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. | 6.32e-06 | 3 | 51 | 2 | 12050117 | |
| Pubmed | Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression. | 6.32e-06 | 3 | 51 | 2 | 16237459 | |
| Pubmed | A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis. | 6.32e-06 | 3 | 51 | 2 | 12384703 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 10350644 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 29145650 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 7870179 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 19041714 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 16141199 | ||
| Pubmed | Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. | 6.32e-06 | 3 | 51 | 2 | 12776737 | |
| Pubmed | Convergence of Canonical and Non-Canonical Wnt Signal: Differential Kat3 Coactivator Usage. | 6.32e-06 | 3 | 51 | 2 | 30836930 | |
| Pubmed | Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation. | 6.32e-06 | 3 | 51 | 2 | 14759370 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 10673036 | ||
| Pubmed | Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. | 6.32e-06 | 3 | 51 | 2 | 12456660 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 22474372 | ||
| Interaction | LATS2 interactions | 4.40e-07 | 289 | 49 | 8 | int:LATS2 | |
| Interaction | CALM3 interactions | 1.59e-06 | 343 | 49 | 8 | int:CALM3 | |
| Interaction | CDC16 interactions | 2.06e-06 | 246 | 49 | 7 | int:CDC16 | |
| Interaction | CDH5 interactions | 6.66e-06 | 109 | 49 | 5 | int:CDH5 | |
| Interaction | PTPN13 interactions | 9.19e-06 | 202 | 49 | 6 | int:PTPN13 | |
| Interaction | SRCAP interactions | 1.40e-05 | 127 | 49 | 5 | int:SRCAP | |
| Interaction | ARID1A interactions | 5.33e-05 | 276 | 49 | 6 | int:ARID1A | |
| Interaction | PPP1R13L interactions | 6.19e-05 | 88 | 49 | 4 | int:PPP1R13L | |
| Interaction | PTPN14 interactions | 6.89e-05 | 177 | 49 | 5 | int:PTPN14 | |
| Interaction | PKN2 interactions | 8.06e-05 | 183 | 49 | 5 | int:PKN2 | |
| Interaction | AMOTL1 interactions | 8.34e-05 | 95 | 49 | 4 | int:AMOTL1 | |
| Interaction | RIC8A interactions | 8.69e-05 | 96 | 49 | 4 | int:RIC8A | |
| Interaction | GAK interactions | 9.39e-05 | 189 | 49 | 5 | int:GAK | |
| Interaction | KMT2A interactions | 1.09e-04 | 314 | 49 | 6 | int:KMT2A | |
| Interaction | LIN7B interactions | 1.35e-04 | 41 | 49 | 3 | int:LIN7B | |
| Interaction | AFDN interactions | 1.50e-04 | 333 | 49 | 6 | int:AFDN | |
| Interaction | KCNB1 interactions | 1.56e-04 | 43 | 49 | 3 | int:KCNB1 | |
| Interaction | ARL15 interactions | 1.63e-04 | 113 | 49 | 4 | int:ARL15 | |
| Interaction | STAT1 interactions | 1.73e-04 | 342 | 49 | 6 | int:STAT1 | |
| Interaction | NAP1L1 interactions | 1.81e-04 | 345 | 49 | 6 | int:NAP1L1 | |
| Interaction | MTDH interactions | 2.05e-04 | 505 | 49 | 7 | int:MTDH | |
| Interaction | HOXB3 interactions | 2.06e-04 | 9 | 49 | 2 | int:HOXB3 | |
| Interaction | KCNV1 interactions | 2.06e-04 | 9 | 49 | 2 | int:KCNV1 | |
| Interaction | ARGFX interactions | 2.06e-04 | 9 | 49 | 2 | int:ARGFX | |
| Interaction | CD79B interactions | 2.19e-04 | 122 | 49 | 4 | int:CD79B | |
| Interaction | CRKL interactions | 2.21e-04 | 227 | 49 | 5 | int:CRKL | |
| Interaction | TRIP6 interactions | 2.21e-04 | 358 | 49 | 6 | int:TRIP6 | |
| Interaction | HBP1 interactions | 2.26e-04 | 123 | 49 | 4 | int:HBP1 | |
| Interaction | LIMD1 interactions | 2.34e-04 | 124 | 49 | 4 | int:LIMD1 | |
| Interaction | TRIM4 interactions | 2.44e-04 | 50 | 49 | 3 | int:TRIM4 | |
| Interaction | NUMB interactions | 2.44e-04 | 232 | 49 | 5 | int:NUMB | |
| Interaction | PPP1CA interactions | 2.50e-04 | 696 | 49 | 8 | int:PPP1CA | |
| Interaction | CDC20 interactions | 2.54e-04 | 234 | 49 | 5 | int:CDC20 | |
| Interaction | PARP1 interactions | PTPN13 KIDINS220 FLYWCH1 SENP3 PLEKHA4 GNL2 MSL1 ITPRID2 CREBBP EP300 PTK2 | 2.57e-04 | 1316 | 49 | 11 | int:PARP1 |
| Interaction | ZC3H12C interactions | 2.57e-04 | 10 | 49 | 2 | int:ZC3H12C | |
| Interaction | EID1 interactions | 2.59e-04 | 51 | 49 | 3 | int:EID1 | |
| Interaction | YWHAZ interactions | TANC2 NRG1 KANK1 PTPN13 ROGDI KCNQ5 PLEKHA4 AFDN WWTR1 ITPRID2 EP300 | 2.62e-04 | 1319 | 49 | 11 | int:YWHAZ |
| Interaction | SPATS2L interactions | 2.64e-04 | 128 | 49 | 4 | int:SPATS2L | |
| Interaction | YWHAH interactions | TANC2 KANK1 PTPN13 KCNQ5 IQCB1 PLEKHA4 AFDN WWTR1 ITPRID2 CREBBP | 2.68e-04 | 1102 | 49 | 10 | int:YWHAH |
| Interaction | TP53BP2 interactions | 2.91e-04 | 241 | 49 | 5 | int:TP53BP2 | |
| Interaction | GPHN interactions | 3.14e-04 | 134 | 49 | 4 | int:GPHN | |
| Interaction | EIF4E2 interactions | 3.20e-04 | 246 | 49 | 5 | int:EIF4E2 | |
| Interaction | KPNB1 interactions | 3.23e-04 | 544 | 49 | 7 | int:KPNB1 | |
| Interaction | RBM27 interactions | 3.42e-04 | 137 | 49 | 4 | int:RBM27 | |
| Interaction | DUS3L interactions | 3.42e-04 | 56 | 49 | 3 | int:DUS3L | |
| Interaction | SH3RF3 interactions | 3.42e-04 | 56 | 49 | 3 | int:SH3RF3 | |
| Interaction | UBE2S interactions | 3.51e-04 | 138 | 49 | 4 | int:UBE2S | |
| Interaction | ANAPC5 interactions | 3.51e-04 | 138 | 49 | 4 | int:ANAPC5 | |
| Interaction | MAP4K4 interactions | 3.71e-04 | 254 | 49 | 5 | int:MAP4K4 | |
| Interaction | EFNB1 interactions | 3.78e-04 | 255 | 49 | 5 | int:EFNB1 | |
| Interaction | SLC30A4 interactions | 3.79e-04 | 58 | 49 | 3 | int:SLC30A4 | |
| Interaction | RPS6KA5 interactions | 4.13e-04 | 144 | 49 | 4 | int:RPS6KA5 | |
| Interaction | ABCC9 interactions | 4.44e-04 | 13 | 49 | 2 | int:ABCC9 | |
| Interaction | SCRIB interactions | 4.58e-04 | 266 | 49 | 5 | int:SCRIB | |
| Interaction | CEBPD interactions | 4.62e-04 | 62 | 49 | 3 | int:CEBPD | |
| Interaction | HOXA10 interactions | 4.62e-04 | 62 | 49 | 3 | int:HOXA10 | |
| Interaction | MDC1 interactions | 4.80e-04 | 414 | 49 | 6 | int:MDC1 | |
| Interaction | MAPK10 interactions | 4.84e-04 | 63 | 49 | 3 | int:MAPK10 | |
| Interaction | CCNA1 interactions | 4.84e-04 | 63 | 49 | 3 | int:CCNA1 | |
| Interaction | CGN interactions | 5.06e-04 | 152 | 49 | 4 | int:CGN | |
| Interaction | WWTR1 interactions | 5.31e-04 | 422 | 49 | 6 | int:WWTR1 | |
| Interaction | ABT1 interactions | 5.38e-04 | 423 | 49 | 6 | int:ABT1 | |
| Interaction | NUP35 interactions | 5.45e-04 | 424 | 49 | 6 | int:NUP35 | |
| Interaction | KCNB2 interactions | 5.55e-04 | 66 | 49 | 3 | int:KCNB2 | |
| Interaction | SLTM interactions | 5.58e-04 | 156 | 49 | 4 | int:SLTM | |
| Interaction | CDC25C interactions | 5.58e-04 | 156 | 49 | 4 | int:CDC25C | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 1.11e-04 | 426 | 51 | 5 | chr16p13 | |
| Cytoband | 16p13.3 | 1.60e-04 | 244 | 51 | 4 | 16p13.3 | |
| Cytoband | 5p15.1 | 6.25e-04 | 33 | 51 | 2 | 5p15.1 | |
| GeneFamily | PDZ domain containing | 7.72e-06 | 152 | 33 | 5 | 1220 | |
| GeneFamily | Potassium voltage-gated channels | 5.23e-05 | 40 | 33 | 3 | 274 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.32e-04 | 17 | 33 | 2 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.85e-04 | 18 | 33 | 2 | 91 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.53e-03 | 41 | 33 | 2 | 1298 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 3.75e-03 | 50 | 33 | 2 | 1293 | |
| GeneFamily | Ankyrin repeat domain containing | 9.61e-03 | 242 | 33 | 3 | 403 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | 2.13e-05 | 854 | 48 | 9 | M1533 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | 2.89e-05 | 888 | 48 | 9 | MM1018 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.28e-06 | 200 | 51 | 5 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.28e-06 | 200 | 51 | 5 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.22e-05 | 158 | 51 | 4 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.79e-05 | 175 | 51 | 4 | fa16c6ba08dc0cc22e8cf049db0577811d080df6 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 178 | 51 | 4 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-05 | 183 | 51 | 4 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-05 | 183 | 51 | 4 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.82e-05 | 184 | 51 | 4 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 6.33e-05 | 188 | 51 | 4 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | facs-Skin|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-05 | 191 | 51 | 4 | ae524103331fa53fa82888dbb567fc36abcee7e0 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.01e-05 | 193 | 51 | 4 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.15e-05 | 194 | 51 | 4 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.15e-05 | 194 | 51 | 4 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.15e-05 | 194 | 51 | 4 | 5771a28a61f4d9b5479891f3224909ab003cb241 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.44e-05 | 196 | 51 | 4 | acbb493dbb49a33f20cf11106363f7ed51209706 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.73e-05 | 198 | 51 | 4 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.73e-05 | 198 | 51 | 4 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-05 | 198 | 51 | 4 | 71e847e8c24744d6df4a960348ad2ecf310373b4 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.73e-05 | 198 | 51 | 4 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 7.89e-05 | 199 | 51 | 4 | fd75dccb37d96448edf72b7d042b06833d4ead24 | |
| ToppCell | Transverse-(2)_B_cell-(24)_B_cell_cycling|Transverse / shred on region, Cell_type, and subtype | 8.04e-05 | 200 | 51 | 4 | e3f9736227151f23f0e331eec0a7a15ce464b517 | |
| ToppCell | Transverse-B_cell-B_cell_cycling|Transverse / Region, Cell class and subclass | 8.04e-05 | 200 | 51 | 4 | 0e270f8019d9f22068ca426d661937262a5cd331 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.04e-05 | 200 | 51 | 4 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| Computational | Neighborhood of MAP4K4 | 1.40e-04 | 172 | 32 | 5 | GCM_MAP4K4 | |
| Disease | Menke-Hennekam syndrome | 2.70e-06 | 2 | 49 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 2.70e-06 | 2 | 49 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 2.70e-06 | 2 | 49 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 2.70e-06 | 2 | 49 | 2 | C4551859 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 2.70e-06 | 2 | 49 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 2.70e-06 | 2 | 49 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 2.70e-06 | 2 | 49 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 2.70e-06 | 2 | 49 | 2 | C0035934 | |
| Disease | angiotensin-converting enzyme measurement | 9.65e-05 | 9 | 49 | 2 | EFO_0006515 | |
| Disease | Sclerocystic Ovaries | 9.72e-05 | 144 | 49 | 4 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 9.72e-05 | 144 | 49 | 4 | C0032460 | |
| Disease | long QT syndrome (implicated_via_orthology) | 1.21e-04 | 10 | 49 | 2 | DOID:2843 (implicated_via_orthology) | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 2.08e-04 | 13 | 49 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 6.21e-04 | 100 | 49 | 3 | C0010606 | |
| Disease | Intellectual Disability | 8.60e-04 | 447 | 49 | 5 | C3714756 | |
| Disease | Squamous cell carcinoma | 1.16e-03 | 124 | 49 | 3 | C0007137 | |
| Disease | heart conduction disease (implicated_via_orthology) | 1.30e-03 | 32 | 49 | 2 | DOID:10273 (implicated_via_orthology) | |
| Disease | microcephaly (implicated_via_orthology) | 1.30e-03 | 32 | 49 | 2 | DOID:10907 (implicated_via_orthology) | |
| Disease | lung squamous cell carcinoma (is_marker_for) | 1.64e-03 | 36 | 49 | 2 | DOID:3907 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MLIMQRLEAERRARL | 1591 | P55196 | |
| RLQQAQMLRRRMASM | 1821 | Q09472 | |
| LMRNRNRKVSRMRCL | 496 | Q8NEB7 | |
| RRVTIMPRDMQLARR | 116 | P0DPK5 | |
| RREMQSQSVMLALRR | 266 | Q9BXJ3 | |
| QAQLMRRRMATMNTR | 1861 | Q92793 | |
| ATLIQRRFRTLMMRR | 2266 | Q8IZT6 | |
| QRRRREFMMRSRLEC | 956 | Q6ZMN7 | |
| QLMNLIRSVRTVMRV | 51 | Q9Y5U9 | |
| DRLRQSLRSERNNMM | 276 | Q02297 | |
| LQRAGVTLRVLRMMR | 281 | Q8TAE7 | |
| MEQLNRRYQSIRRTM | 856 | Q9P2P5 | |
| SLNNRRTLMLMAQMR | 31 | P01570 | |
| RRQMQRTITRQMSFD | 906 | Q9ULH0 | |
| NMRDRATIRRLNMYR | 31 | Q13823 | |
| MRRNNSMRRNNSIRR | 386 | Q15842 | |
| PMAQRRRFTRVEMAR | 516 | Q9UPT6 | |
| RLEAMMRRSLERTQQ | 126 | Q96T17 | |
| RAITQGRRVMVMRRH | 551 | Q4VC44 | |
| RRREQLLREMQQMAS | 1311 | O75882 | |
| RLRSSMSENRMSRRI | 156 | Q6DN90 | |
| LRSLRFLQILRMVRM | 231 | Q9NR82 | |
| RRVTIMPRDMQLARR | 116 | P0DPK2 | |
| RFLQILRMIRMDRRG | 201 | O43526 | |
| SVSLRMQQDLMRSRL | 396 | Q5KU26 | |
| TRRRLEQERATMQMT | 161 | Q14678 | |
| ASVLQNLRTAMRRQM | 576 | O75074 | |
| NMDSVGRIQMRTRRT | 36 | Q9HAV0 | |
| NAEMTRQLREREQRM | 371 | Q15070 | |
| TLLARIERMERRMQL | 256 | Q68DK7 | |
| MEMFQRAQALRRRAE | 201 | E9PIF3 | |
| RLRNCIISLVTQRMM | 236 | Q13868 | |
| LQVMRRSLNLFRTQM | 961 | P28290 | |
| MSQMNRQTRRRRRLR | 156 | Q86Y01 | |
| RMMPIRRSAQLERIR | 46 | Q8N3R9 | |
| VDVVRTRMMNQRVLR | 221 | Q5SVS4 | |
| TRMMNQRVLRDGRCS | 226 | Q5SVS4 | |
| VLMARRRMPRSNSQE | 556 | Q02410 | |
| MTISMRQRLAELRQR | 736 | O60336 | |
| RQRAMRLSRELQLSM | 356 | Q15051 | |
| MQRMLIVRSLRQDRV | 3786 | Q9P225 | |
| TMVSNRLRLALVRMQ | 2331 | Q12923 | |
| MDAVMLQLTRARNRL | 146 | Q9GZN7 | |
| RPRMSAQEQLERMRR | 586 | Q9H4M7 | |
| QQEERMRMESRRQAT | 686 | Q05397 | |
| EMRRRQEEAMRRLAS | 436 | Q9HCD6 | |
| TCSQRRRRAMRAFRM | 121 | Q9H4L4 | |
| MLRDQNESCTRNMRR | 3546 | Q63HN8 | |
| MRRREAAFRSMLRQA | 626 | Q6NWY9 | |
| LQAQRLVMRRMSSRL | 206 | Q8WTV1 | |
| MSFRAARLSMRNRRN | 1 | Q7Z2W7 | |
| RLQRIQMERERIRMR | 236 | Q9GZV5 |